August 27, 2022

Featured Opportunity

Internal Call for Core Research Projects

The existing CDC-funded Injury Prevention Research Center at Emory is seeking proposals for four (4) core research projects that would be funded through its 5-year competitive renewal. Projects will run for either 2 or 3 years (either 2024-2026 or 2026-2029). To promote equity and transparency in the selection process, the team is soliciting abstracts from investigators interested in leading one of these core research projects.

Deadline: Internal abstracts due September 12th

Contact Stephanie Verna at if you have any questions.

View RFP


Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional)

This FOA invites applications that propose research projects that test promising digital healthcare interventions aimed at improving the quality of care and healthcare services delivery at the point of care. This FOA will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities and up to 3 years of R33 support for expanded activities.

Deadline: 10/16/2022

Research on Emerging Technologies for Teaching and Learning (RETTL)

The purpose of the Research on Emerging Technologies for Teaching and Learning (RETTL) program is to fund exploratory and synergistic research in emerging technologies (including, but not limited to, artificial intelligence (AI), robotics, and immersive or augmenting technologies) for teaching and learning in the future. The program accepts proposals that focus on learning, teaching, or a combination of both.

Deadline: 10/17/2022

Infectious Diseases

Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed)

The purpose of the Funding Opportunity Announcement is to invite applications to identify and characterize microbial metabolites that will establish causal associations between microbial metabolism and host health and disease.

Deadline: 10/20/2022

Identifying Host Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection (R01 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to support mechanistic studies on host cell death pathways and their effect on immune responses to Mycobacterium tuberculosis (Mtb) and Mtb/HIV co-infection to identify immune targets for the development of host-directed therapies.

Deadline: 12/07/2022

Brain Health

BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)

Guided by the goals established in BRAIN 2025 this funding opportunity from the NIH Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative is intended to support efforts addressing core ethical issues associated with research focused on the human brain and resulting from emerging technologies and advancements supported by the BRAIN Initiative.

Deadline: 10/11/2022

Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites applications that apply a cross-disciplinary and team science approach to gain a comprehensive mechanistic understanding of the impact of sex differences on the molecular trajectories of brain aging on the phenotypes of risk and resilience to Alzheimer's disease (AD) and AD-related dementias (ADRD), and on the molecular determinants underlying responsiveness to pharmacologic and non-pharmacologic interventions.

Letter of intent deadline: 10/11/2022


Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed)

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) will support the program "Cancer Target Discovery and Development” (CTD2, pronounced cee-tee-dee-squared). CTD2 is focused on efforts that advance cancer research by bridging the knowledge gap between the large volumes of comprehensive molecular characterizations of many cancer types and studies of the underlying etiology of cancer development, progression, and/or metastasis.

Letter of intent deadline: 9/06/2022

Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required)

Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) intends to accelerate the development, innovation, and establishment of adoptive cellular therapy clinical trials for the treatment of adult patients (18 years or older) with solid tumors.

Letter of intent deadline: 9/28/2022

Global Health

Environmental Convergence Opportunities in Chemical, Bioengineering, Environmental, and Transport Systems (ECO-CBET)

Creating effective solutions to our most pressing environmental and sustainability challenges requires imaginative thinking - the kind that evolves when researchers from disparate fields, expertise, or perspectives fully immerse themselves in work toward a common goal.

Preliminary Proposals due 9/19/2022

Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Monkeypox Virus

This Dear Colleague Letter (DCL) seeks to enhance and accelerate research intended to better understand the spread of the monkeypox virus, inform and educate about the science of virus transmission and prevention, and encourage the development of processes and actions to address this global challenge.

Social Justice / DEI

Robert Wood Johnson Foundation – Policies to Build and Sustain Economic Security and Wealth for Families and Communities of Color

The Robert Wood Johnson Foundation (RWJF) is committed to building a Culture of Health that provides everyone in America a fair and just opportunity for health and well-being. Racial disparities in COVID-19 infections and deaths have brought to the forefront well-documented and longstanding inequities in family and community wealth and opportunity. Upending centuries of policy decisions that perpetuated racism will require significant transformation to elevate the voices of communities historically excluded from decision-making.

Please contact Nicole Dancz-Bal in OCFR if interested in submitting. 

Letter of Intent Deadline: 09/07/2022

Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to support studies that expand the use of existing data resources to drive new discoveries that can lead to a better understanding of the relationship between early life social determinants of health (SDOH), adverse childhood experiences (ACEs), AD/ADRD biomarkers, and the development of cognitive impairment and dementia, especially in populations experiencing health disparities.

Deadline: 10/05/2022

ARPA-H Seed Funding

To help position Emory faculty for the launch of ARPA-H, the Office of the Sr. Vice President for Research, in consultation with the Office of the Provost, has created the ARPA-H seed funds program. These seeds are intended to lead to competitive ARPA-H proposals. In alignment with ARPA-H’s expected culture and processes, this seed funding aims to rapidly de-risk bold, revolutionary concepts in the biomedical and health sciences.

Given the unique culture of ARPA-H and its reliance on program managers to make funding decisions based on the Heilmeier Questions (and not peer review), awardees will receive tailored training and feedback on their responses to the Heilmeier Questions. During and after the conclusion of the seed project, seed recipients will work with the Office of Research Development to refine their ARPA-H pitch.

Learn more about ARPA-H

View RFP Document

Upcoming Events

We're excited to announce the fall 2022 Constructive Collisions event series. Save the date for the events below. Registration information will be provided a later date.

Neuroscience x Environmental Health

Tuesday, October 11th

12pm – 2pm

RSPH, Klamon Room

Global Oncology

Thursday, October 20th

10am – 4pm

RSPH, Klamon Room

AI.Humanity with a Social Justice Lens w/ GA Tech

Wednesday, November 9th

3pm – 6pm

Coda at Tech Square

Finding Funding

Funding Opportunities Calendar 

A comprehensive archive of past, present and upcoming opportunities can be found on the SVPR funding calendar. Click the link below to view.

SVPR Funding Calendar

Search Tool for Corporate and Foundation Funding Opportunities
The Office of Corporate Relations and the Office of Foundation Relations have teamed up to create this resource site to provide a curated list of current funding opportunities and other resources. This site will help promote connections between Emory colleagues and corporate/foundation partners.


Universities involved in research often need to run competitions for grant funding, whether for internal grant dollars or limited submission opportunities through external sponsors.

Link to SharePoint Search Tool

Free access available with Emory Email address. Formally IRIS. Provides access to the University Community to conduct funding searches. The database is provides funding opportunities for the physical and life sciences, social sciences, arts, and humanities. Link for More Information is a central storehouse for information on over 1,000 grant programs from over 27 federal agencies. Interested applicants can search for relevant funding opportunities by Keyword or Category or browse opportunities by agency. The portal is also a central source to apply for federal grants. Information on the processes for proposal submission through can be found in Proposal Submission.
Foundation Directory
Free access available through Databases@Emory. This database, produced by the nation's leading authority on philanthropy, includes extensive program details for thousands of leading foundations; detailed application guidelines for more than 7,000 grants; and a searchable file of approximately half a million grants.
Visit our website